Clinical Trial Update: Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating escitalopram for preventing depression in head and neck cancer patients undergoing treatment; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: University of Nebraska | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2014-02-14